Tingo Medical

Tingo Medical is a medical device company that is developing a continuous glucose monitoring (CGM) system for managing diabetes. The company has identified a system with the potential to deliver more accurate glucose measurements at a competitive production price.

Investment rationale

CGM is one of the most attractive markets within MedTech, growing at 24% p.a. Tingo's sensing technology has potential to impact millions of lives by improving access to CGM. The founders have a demonstrated history of developing medical devices with several past exits in the field of diabetes.

Headquarters: Modiin-Maccabim-Reut, Israel

Fund: MIM I